About Golden Drugs Private Limited
Data last updated: 06 July 2025
Golden Drugs Private Limited was a private limited company based in Bangalore, Karnataka, India, operated as a subsidiary of Bal Pharma Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 27 August 2012.
Registered with ROC Bangalore under CIN U24232KA2012PTC157474.
Capital: an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹3.59 Cr. Formerly known as Golden Drug Private Limited. It was led by directors Ravindrakumar Kothari and Shailesh Dheerajmal Siroya.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 10/1 Laxmi Narayan Complex 5Th Floor Palace Road, Bangalore, Karnataka, India – 560052.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.8 Cr, a decline of 22% compared to the previous year.
The company had a reported workforce of approximately 80 employees prior to being dissolved. It operated as a subsidiary of Bal Pharma Limited.
As per MCA filings, the company had open charges of ₹20 Cr and satisfied charges of ₹24.5 Cr on record.
The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is balpharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address10/1 Laxmi Narayan Complex 5Th Floor Palace Road, Bangalore, Karnataka, India – 560052
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Golden Drugs Private Limited
Golden Drugs Private Limited has one previous CIN (Corporate Identification Number): U24232RJ2012PTC039907. The current CIN is U24232KA2012PTC157474, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232KA2012PTC157474 | Current |
| U24232RJ2012PTC039907 | Previous |
Business Activity of Golden Drugs Private Limited
Golden Drugs Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Golden Drugs Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Golden Drugs Private Limited
Golden Drugs Private Limited is audited by K N & Associates for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K N & Associates | Locked | Locked | Locked |
Complete auditor history for Golden Drugs Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Golden Drugs Private Limited
Golden Drugs Private Limited is currently managed by 2 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ravindrakumar Kothari
Also directs:
Balance Clinics Llp, Bal Pharma Limited, Lifezen Healthcare Private Limited and 2 more
|
Director | 15 Nov 2018 | 7 Years 8 Months | As last reported |
|
Shailesh Dheerajmal Siroya
Also directs:
Balance Clinics Llp, Bal Pharma Limited, Lifezen Healthcare Private Limited and 3 more
|
Director | 12 Apr 2018 | 8 Years 4 Months | As last reported |
Financials of Golden Drugs Private Limited FY 2024 filings available
Golden Drugs Private Limited reported revenue of ₹5.8 Cr (down 22.00% YoY) for FY 2024.
Ten-year financial statements for Golden Drugs Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Golden Drugs Private Limited
Shareholding and ownership data for Golden Drugs Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Golden Drugs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2018 | Tata Capital Financial Services Limited | ₹15 Cr | Satisfied |
| 15 Oct 2014 | Punjab National Bank | ₹4 Cr | Satisfied |
| 15 Oct 2014 | Punjab National Bank | ₹5.5 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Golden Drugs Private Limited
Golden Drugs Private Limited has a workforce of 80 employees as of Mar 08, 2025.
Employee and EPFO history for Golden Drugs Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Golden Drugs Private Limited
GST registrations and filing compliance for Golden Drugs Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Golden Drugs Private Limited
Credit ratings, litigation, and regulatory alerts for Golden Drugs Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Golden Drugs Private Limited
MSME payment history for Golden Drugs Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Golden Drugs Private Limited
Corporate group structure for Golden Drugs Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Golden Drugs Private Limited
MCA filings and documents for Golden Drugs Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Golden Drugs Private Limited
Recent News on Golden Drugs Private Limited
Frequently Asked Questions about Golden Drugs Private Limited
Golden Drugs Private Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Golden Drugs Private Limited is a amalgamated private limited company in the pharma sector based in Bangalore, Karnataka, India. It was incorporated on 27 August 2012 and is registered under CIN U24232KA2012PTC157474. The company was amalgamated as per MCA records and no longer exists as a legal entity.
Golden Drugs Private Limited was incorporated on 27 August 2012. Registered with ROC Bangalore.
The current directors of Golden Drugs Private Limited are:
- Ravindrakumar Kothari - Director
- Shailesh Dheerajmal Siroya - Director
The CIN (Corporate Identification Number) of Golden Drugs Private Limited is U24232KA2012PTC157474. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Golden Drugs Private Limited is pharma. The company specifically operates in api manufacturers.